Verdence Capital Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $802K | Buy |
12,407
+61
| +0.5% | +$4.3K | 0.05% | 335 |
|
|
2025
Q4 | $831K | Sell |
12,346
-679
| -5% | -$45.7K | 0.05% | 308 |
|
|
2025
Q3 | $858K | Sell |
13,025
-512
| -4% | -$34K | 0.05% | 328 |
|
|
2025
Q2 | $704K | Sell |
13,537
-64
| -0.5% | -$3.64K | 0.05% | 321 |
|
|
2025
Q1 | $868K | Buy |
13,601
+370
| +3% | +$21.5K | 0.07% | 266 |
|
|
2024
Q4 | $633K | Sell |
13,231
-1
| -0% | -$51 | 0.05% | 319 |
|
|
2024
Q3 | $757K | Buy |
13,232
+252
| +2% | +$14.4K | 0.06% | 301 |
|
|
2024
Q2 | $680K | Sell |
12,980
-60
| -0.5% | -$2.63K | 0.06% | 302 |
|
|
2024
Q1 | $530K | Sell |
13,040
-1,534
| -11% | -$57.5K | 0.05% | 338 |
|
|
2023
Q4 | $539K | Buy |
14,574
+140
| +1% | +$5.27K | 0.05% | 322 |
|
|
2023
Q3 | $551K | Sell |
14,434
-190
| -1% | -$7.78K | 0.06% | 310 |
|
|
2023
Q2 | $527K | Buy |
14,624
+206
| +1% | +$7.03K | 0.06% | 308 |
|
|
2023
Q1 | $551K | Sell |
14,418
-344
| -2% | -$16.1K | 0.07% | 292 |
|
|
2022
Q4 | $840K | Sell |
14,762
-914
| -6% | -$46.8K | 0.1% | 203 |
|
|
2022
Q3 | $620K | Buy |
15,676
+148
| +1% | +$6.54K | 0.09% | 236 |
|
|
2022
Q2 | $683K | Buy |
15,528
+1,507
| +11% | +$65.2K | 0.09% | 235 |
|
|
2022
Q1 | $559K | Buy |
14,021
+251
| +2% | +$8.94K | 0.06% | 280 |
|
|
2021
Q4 | $554K | Buy |
13,770
+2,282
| +20% | +$85.2K | 0.07% | 272 |
|
|
2021
Q3 | $467K | Sell |
11,488
-7
| -0.1% | -$293 | 0.06% | 288 |
|
|
2021
Q2 | $522K | Sell |
11,495
-36
| -0.3% | -$1.59K | 0.07% | 248 |
|
|
2021
Q1 | $481K | Sell |
11,531
-20
| -0.2% | -$913 | 0.08% | 230 |
|
|
2020
Q4 | $493K | Buy |
11,551
+163
| +1% | +$5.86K | 0.09% | 210 |
|
|
2020
Q3 | $299K | Hold |
11,388
| – | – | 0.07% | 252 |
|
|
2020
Q2 | $305K | Hold |
11,388
| – | – | 0.08% | 239 |
|
|
2020
Q1 | $205K | Hold |
11,388
| – | – | 0.06% | 276 |
|
|
2019
Q4 | $202K | Hold |
11,388
| – | – | 0.05% | 310 |
|
|
2019
Q3 | $177K | Hold |
11,388
| – | – | 0.05% | 290 |
|
|
2019
Q2 | $196K | Hold |
11,388
| – | – | 0.06% | 276 |
|
|
2019
Q1 | $183K | Hold |
11,388
| – | – | 0.05% | 256 |
|
|
2018
Q4 | $167K | Hold |
11,388
| – | – | 0.05% | 228 |
|
|
2018
Q3 | $207K | Hold |
11,388
| – | – | 0.05% | 248 |
|
|
2018
Q2 | $192K | Hold |
11,388
| – | – | 0.05% | 274 |
|
|
2018
Q1 | $223K | Hold |
11,388
| – | – | 0.05% | 255 |
|
|
2017
Q4 | $231K | Buy |
+11,388
| New | +$209K | 0.06% | 244 |
|
Other funds holding HALO
VCM
VPM
Verdence Capital Advisors's HALO Position: Q1 2026 in Review
Verdence Capital Advisors increased its Halozyme (HALO) stake by 0.49% in Q1 2026, buying an estimated $4.3K and bringing the position to 12,407 shares worth $802K. The position accounts for 0.05% of the portfolio, ranked #335.
Verdence Capital Advisors first reported a position in HALO in Q4 2017 and has held it in 34 quarters since. The position peaked at $868K in Q1 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Verdence Capital Advisors held 12,407 shares of Halozyme worth $802K as of Q1 2026.
- Verdence Capital Advisors bought 61 Halozyme shares in Q1 2026, an estimated $4.3K.
- Halozyme made up 0.05% of Verdence Capital Advisors's portfolio in Q1 2026, its #335 holding.
- Verdence Capital Advisors first reported a position in Halozyme in Q4 2017 and has held it in 34 quarters since.
- Verdence Capital Advisors's Halozyme position peaked at $868K in Q1 2025.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Verdence Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.